Raymond James Financial’s Verona Pharma VRNA Stock Holding History

Raymond James Financial’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,302	Closed	-$779K	–	5343
2025 Q3	$779K	Sell	7,302 -13,746	-65%	-$1.44M	﹤0.01%	3845
2025 Q2	$1.99M	Buy	21,048 +14,426	+218%	+$1.07M	﹤0.01%	3085
2025 Q1	$420K	Buy	6,622 +1,767	+36%	+$106K	﹤0.01%	4038
2024 Q4	$225K	Buy	+4,855	New	+$182K	﹤0.01%	4334

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Raymond James Financial's VRNA Position: Q4 2025 in Review

Raymond James Financial sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 7,302 shares — an estimated $779K sold.

Raymond James Financial first reported a position in VRNA in Q4 2024 and held it in 4 quarters. The position peaked at $1.99M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Raymond James Financial reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Raymond James Financial sold 7,302 Verona Pharma shares in Q4 2025, an estimated $779K.
Raymond James Financial first reported a position in Verona Pharma in Q4 2024 and held it in 4 quarters.
Raymond James Financial's Verona Pharma position peaked at $1.99M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Raymond James Financial's 13F filing for Q4 2025, filed 18 Feb 2026.